Abstract
The potential involvement of platelet activating factor (PAF, 1-O-alkyl 2-O-acetyl-sn-glycero-3-phosphocholine) in aggravation of ischemic brain injury has been recently postulated. Reported evidences in support of this thesis include increases of brain PAF concentration during ischemia and the neuroprotective effect exerted by PAF antagonists. In this article, we demonstrate that several PAF-mediated biochemical responses in synaptoneurosomes in vitro resemble these observed previously in schemic brain and are widely acknowledged as the potentially causal factors in this pathology. In synaptoneurosomes prepared from rat hippocampus, 10 nM PAF caused an observable elevation of intracellular calcium as measured by fluorescence Fura-2A probe. A similar elevation of synaptoneurosomal [Ca2+]i was evoked by 1 mM glutamate treatment. As an effect of calcium entry after PAF application, a translocation of protein kinase C (PKC) toward plasma membranes was demonstrated by3H-labeled phorbol-binding method. It was followed by an increase of 50 kDa proteolytic fragment of the enzyme (PKM) recognized on Western blots with anti-PKC antibody. Incubation of synaptoneurosomes in the presence of calcium chelators abolished these effects of PAF and significantly decreased the content of PKC in the membranes. Furthermore, PAF treatment markedly attenuated the receptor- and postreceptor-activated cAMP accumulation in synaptoneurosomes. The decrease of cAMP level seems to be secondary to the PAF-induced calcium entry with subsequent activation of cAMP-specific phosphodiesterase, since it was completely blocked by IBMX, a potent inhibitor of this enzyme. Our observations indicate that PAF in a concentration found in ischemic brain can elevate [Ca2+]i and potentiate calcium-dependent intracellular signalling in synaptoneurosomes in vitro, including PKC translocation/activation and proteolysis, followed by IBMX-sensitive inhibition of cAMP production. The relative contribution of these events to ischemic brain injury is currently under extensive investigation.
Similar content being viewed by others
Abbreviations
- IBMX:
-
3-isobutyl-1-methylxanthine
- Fura 2AM:
-
fura-2-acetoxy-methyl-ester
- DMSO:
-
dimethyl-sulfoxide
- [Ca2+]i :
-
intracellular free calcium concentration
- PBDu:
-
4-β-phorbol-12, 13-dibutyrate
- PAF:
-
platelet-activating-factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphorylcholine)
- Lyso-PAF:
-
1-O-hexadecyl-sn-glycero-3-phosphocholine
- PKC:
-
protein kinase C
- NE:
-
norepinephrine
- 2CA:
-
2-chloroadenosine
- BN52021:
-
specific PAF receptor antagonist belonging to ginkgolides
References
Alger B., Dhanjal S. S., Dingledine R., Garthwaite J., Henderson G., King G., Lipton P., North A. Schwartzkroin P., Sears T., Segal M., Whittingham T., and Williams J. (1984) Brain slice methods, inBrain Slices (Dingledine R. ed.), pp. 381–437. Plenum, New York.
Bazan N. G., Clark G. D., and Marcheselli V. L. (1993a) Regulation of release of excitatory amino acids by a novel presynaptic platelet-activating factor receptor.J. Neurochem. 61 (suppl.) S184.
Bazan N. G., Marcheselli V. L., Mukherjee P. K., and Allan G. (1993b) The platelet activating factor intracellular signaling pathway couples stimulation with immediate-early gene expression.J. Neurochem. 61 (suppl.) S59.
Bazan N. G., Squinto S. P., Braquet P., Panetta T., and Marcheselli V. L. (1991) Review: Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: Intracellular PAF binding sites and activation of a Fos/Jun/AP1 transcriptional signaling system.Lipids 26, 1236–1242.
Birkle D. L., Kurian P., Braquet P., and Bazan N. G. (1988) Platelet-activating factor antagonist BN 52021 decreases accumulation of free polyunsaturated fatty acids in mouse brain during ischemia and electroconvulsive shock.J. Neurochem. 51, 1900–1905.
Bito H., Nakamura M., Honda Z., Izumi T., Iwatsubo T., Seyama Y., Ogura A., Kudo Y., and Shimizu T. (1992) Platelet-activating factor (PAF) receptor in the rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons.Neuron 9, 285–294.
Booth R. G. and Clark J. B. (1978) A rapid method for preparation of relatively pure, metabolically competent synaptosomes from the rat brain.Biochem. J. 176, 365–369.
Bussolino F., Gremo F., Tetta C., Pescarmona G. P., and Camussi G. (1986) Production of platelet-activating factor by chick retina.J. Biol. Chem. 261, 16502–16508.
Catalan R. E., Martinez A. M., Aragones M. D., Garde E., and Diaz G. (1993) Platelet-activating factor stimulates protein kinase C translocation in cerebral microvessels.Biochem. Biophys. Res. Commun. 192, 446–451.
Chandler L. J. and Crews F. T. (1990) Calcium-versus G protein-mediated phosphoinositide hydrolysis in rat cerebral cortical synaptosomes.J. Neurochem. 55, 1022–1030.
Clark G. D., Happel L. T., Zorumski C. G., and Bazan N. G. (1992) Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor.Neuron 9, 1211–1216.
Del Cerro S., Arai S., and Lynch G. (1990) Inhibition of long-term potentiation by an agonist of platelet-activating factor receptors.Behav. Neural Biol. 54, 213–217.
Domańska-Janik K. and Pyłowa S. (1992) Postreceptor modulation of cAMP accumulation in rat brain particulate fraction after ischemia-involvement of protein kinase C.Mol. Chem. Neuropathol. 17, 65–77.
Domańska-Janik K., Pyłowa S., and Zalewska T. (1993) Coupling of adenosine receptors to adenylate cyclase in postischemic rat brain.Cellular Signalling 5, 337–343.
Domańska-Janik K. and Zalewska T. (1992) Effect of brain ischemia on protein kinase C.J. Neurochem. 58, 1432–1439.
Domańska-Janik K., Zabłocka B., and Łazarewicz J. W. (1993) Role of PAF in early cellular response to brain ischemia.22nd FEBS Meeting, Stockholm, Abstract C20: 212, p. 206.
Feig S. and Lipton P. (1990) N-Methyl-D-aspartate receptor activation and Ca2+ account for poor pyramidal cell structure in hippocampal slices.J. Neurochem. 55, 473–483.
Feuerstein G., Yue T.-L., and Lysko P. G. (1990) Platelet-activating factor, a putative mediator in central nervous system injury.Stroke 21, (III), 90–94.
Francescangeli E. and Goracci G. (1989) The de novo biosynthesis of platelet-activating factor in the rat brain.Biochem. Biophys. Res. Commun. 161, 107–112.
Frerichs K. U., Lindsberg P. J., Hallenbeck J. M., and Feuerstein G. Z. (1990) Platelet-activating factor and progressive brain damage following focal brain injury.J. Neurosurg. 73, 223–233.
Grandison L. (1990) Platelet-activating factor induces inositol phosphate accumulation in cultures of rat and bovine anterior pituitary cells.Endocrinology 127, 1786–1791.
Grynkiewicz G., Poenie M., Tsien R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties.J. Biol. Chem. 260, 3440–3450.
Gusovsky F. and Daly J. W. (1988) Formation of inositol phosphates in synaptoneurosomes of guinea pig brain: stimulatory effects of receptor agonists, sodium channels agents and calcium ionophore.Neuropharmacology 27, 95–105.
Hara H., Sukamoto T., and Kogure K. (1993) Mechanism and pathogenesis of ischemia-induced neuronal damage.Prog. Neurobiol. 40, 645–670.
Kikkawa U., Takai Y., Tanaka Y., Miyake R., and Nishizuka Y. (1983) Protein kinase C as possible receptor protein of tumor-promoting phorbol esters.J. Biol. Chem. 258, 11422–11445.
Kornecki E. and Ehrlich Y. H. (1988) Neuroregulatory and neuropathological action of the ether-phospholipid platelet-activating factor.Science 240, 1792–1794.
Kumar R., Harvey S. A. K., Kester M., Hanahan D. J., and Olson M. S. (1988) Production and effects of platelet-activating factor in the rat brain.Biochim. Biophys. Acta 963, 375–383.
Lee T., Malone B., and Snyder F. (1986) A new de novo pathway for the formation of 1-alkyl-2-acetyl-sn-glycerols, precursors of platelet-activating factor.J. Biol. Chem. 261, 5373–5377.
Lindsberg P. J., Hallenbeck J. M., and Feuerstein G. (1991) Platelet-activating factor in stroke and brain injury.Ann. Neurol. 30, 117–129.
Lowry O. H., Rosebrough M. J., Farr A. L., and Randall R. J. (1951) Protein measurement with Folin phenol reagent.J. Biol. Chem. 193, 265–275.
Marcheselli V. L. and Bazan N. G. (1993) Platelet-activating factor (PAF) stimulates glutamic acid release from hippocampal synaptosomes.Soc. Neurosci. Abstract 19, 1779.
Marcheselli V. L., Rossowska M. J., Domingo M.-T., Braquet P., and Bazan N. G. (1990) Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex.J. Biol. Chem. 265, 9140–9145.
Murphy S. and Welk G. (1990) Hydrolysis of polyphosphoinositides in astrocytes by platelet-activating factor.Eur. J. Pharmacol. 188, 399–401.
Panetta T., Marcheselli V. L., Braquet P., and Bazan N. G. (1989) Arachidonic acid metabolism and cerebral blood flow in the normal, ischemic, and reperfused gerbil brain. Inhibition of ischemia-reperfusion-induced cerebral injury by platelet-activating factor antagonist (BN 52021).Ann. N.Y. Acad. Sci. 559, 340–351.
Panetta T., Marcheselli V. L., Braquet P., Spinnewyn B., and Bazan N. G. (1987) Effect of platelet-activating factor antagonist (BN 52021) on free fatty acids, diacylgycerols, polyphosphoinositides, and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injury.Biochem. Biophys. Res. Commun. 149, 580–587.
Prehn J. H. M. and Krieglstein J. (1993) Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo.J. Neurosci. Res. 34, 179–188.
Siesjo B. K. and Bengtsson F. (1989) Calcium fluxes, calcium antagonists and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression. A unifying hypothesis.J. Cereb. Blood Flow Metab. 9, 127–140.
Sogos V., Bussolino F., Pilia E., Torelli S., and Gremo F. (1990) Acetylcholine-induced production of platelet-activating factor by human fetal brain cells in culture.J. Neurosci. Res. 27, 706–711.
Spinnewyn B., Blauet N., Clostre F., and Braquet P. (1988) Protective effects of ginkgolides in cerebral postischemic phase in mongolian gerbils, inGinkgolides-Chemistry, Biology, Pharmacology and Clinical Perspectives, (Braquet P., ed.), pp. 665–679, J.R. Prous Sci. Pub. SA.
Tanaka Y., Miyate R., Kikkawa U., and Nishizuka Y. (1986) Rapid assay of binding of tumor-promoting phorbol esters to protein kinase C.J. Biochem. 99, 257–261.
Tokumura A., Kamiyasu K., Takauchi K., and Tsukatani H. (1987) Evidence for existance of various homologues and analogues of platelet-activating factor in a lipid extract from bovine brain.Biochem. Biophys. Res. Commun. 145, 415–425.
Verhage M., Besselsen E., Da Silva F. H. L., and Ghijsen W. E. J. M. (1988) Evaluation of the Ca2+ concentration in purified nerve terminals: relationship between Ca2+ homeostasis and synaptosomal preparation.J. Neurochem. 51, 1667–1674.
Zabłocka B. and Domańska-Janik K. (1993) Involvement of protein kinase C in various cellular systems transducting ischemia-evoked signal.Acta Neurobiol. Experiment. 53, 25–29.
Zabłocka B. and Domańska-Janik K. (1994) PAF antagonist, BN 52021, inhibits [3H]D-aspartate release after ischemia in vitro.NeuroReport 6, 85–88.
Zabłocka B., Łukasiuk K., Łazarewicz J. W., and Domańska-Janik K. (1995) Modulation of ischemic signal by antagonists on N-methyl-D-aspartate, nitric oxide synthase and platelet activating factor in gerbil hippocampus.J. Neurosci. Res. 40, 233–240.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Domańska-Janik, K., Zabłocka, B. Modulation of signal transduction in rat synaptoneurosomes by platelet activating factor. Molecular and Chemical Neuropathology 25, 51–67 (1995). https://doi.org/10.1007/BF02815086
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02815086